Iovance Biotherapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-15.8K |
| Depreciation & Amortization | $1.3K |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $0 |
| Net Cash from Operating Activities | $-14.4K |
| Investing Activities | |
| Capital Expenditures | $0 |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $0 |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $19.8K |
| Net Change in Cash | $5.4K |
| Free Cash Flow | $-14.4K |